TrialAllergy2022

Airway remodelling rather than cellular infiltration characterizes both type2 cytokine biomarker-high and -low severe asthma.

Latifa Khalfaoui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.